Tianqin Mao

Statistics

Publications

Citations

400

H-Index

Active since

2021

Affiliations

University of Electronic Science and Technology of China(Current)

Sichuan Cancer Hospital

Sun Yat-sen University

Army Medical University

Southwest Hospital

Tianqin Mao is an author at University of Electronic Science and Technology of China specializing in oncology, esophageal cancer, and squamous cell carcinoma.

ORCID

Publications per year

2021–2024

Publications

Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell Carcinoma

Hong Wu, Xuefeng Leng, Qianshi Liu et al. · Cancer Research · 2023 · 132 citations · Full text

Life Sciences, Microbiology, Oncology +17

Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Wenwu He, Xuefeng Leng, Tianqin Mao et al. · The Oncologist · 2022 · 103 citations · Full text

Medicine, Oncology, Pharmacology +17

EGFR Oncogenic Mutations in NSCLC Impair Macrophage Phagocytosis and Mediate Innate Immune Evasion Through Up-Regulation of CD47

Liyang Hu, Weitao Zhuang, Mao-jian Chen et al. · Journal of Thoracic Oncology · 2024 · 48 citations · Full text

Life Sciences, Molecular Biology, Oncology +11

Mechanism modeling of optimal excess air coefficient for operating in coal fired boiler

Yanhong Wang, Xiaoyu Li, Tianqin Mao et al. · Energy · 2022 · 42 citations

Engineering, Mechanical Engineering, Optimization +6

1373MO JUPITER-06: A randomized, double-blind, phase III study of toripalimab versus placebo in combination with first-line chemotherapy for treatment naive advanced or metastatic esophageal squamous cell carcinoma (ESCC)

R-H. Xu, F. Wang, Chengxu Cui et al. · Annals of Oncology · 2021 · 24 citations

Medicine, Oncology, Pharmacology +13

1–5 of 9